Treatment of systematized verrucous epidermal naevus by aromatic retinoid (Ro. 10-9359). - Suppr | 超能文献

相似文献

1

Treatment of systematized verrucous epidermal naevus by aromatic retinoid (Ro. 10-9359).

Clin Exp Dermatol. 1983 Nov;8(6):647-50. doi: 10.1111/j.1365-2230.1983.tb01835.x.

2

Systemic retinoid therapy of systematized verrucous epidermal nevus (with 1 colour plate).

Dermatologica. 1977;155(4):200-5. doi: 10.1159/000250999.

3

[Epidermal verrucous linear inflammatory hamartoma (3 cases)].

Tunis Med. 1993 Dec;71(12):595-9.

4

Premature epiphyseal closure--a complication of etretinate therapy in children.

J Am Acad Dermatol. 1986 Dec;15(6):1259-62. doi: 10.1016/s0190-9622(86)70300-9.

5

Treatment of inflammatory linear verrucous epidermal naevus with topical vitamin D3.

Br J Dermatol. 1997 Jan;136(1):134-5. doi: 10.1111/j.1365-2133.1997.tb08766.x.

6

Unilateral systematized keratosis follicularis. A variant of Darier's disease or an epidermal naevus (acantholytic dyskeratotic epidermal naevus)?

Br J Dermatol. 1981 Aug;105(2):207-14. doi: 10.1111/j.1365-2133.1981.tb01207.x.

7

Treatment of inflammatory linear verrucous epidermal nevus.炎症性线状疣状表皮痣的治疗

Dermatologica. 1991;182(2):112-4. doi: 10.1159/000247756.

8

Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359).用一种新型芳香维甲酸（Ro 10-9359）治疗皮肤T细胞淋巴瘤。

Arch Dermatol Res. 1982;273(1-2):37-42. doi: 10.1007/BF00509025.

9

Verrucous carcinoma treated with etretinate.

Int J Dermatol. 1987 Jun;26(5):322-3. doi: 10.1111/j.1365-4362.1987.tb00198.x.

10

Successful treatment of a widespread inflammatory verrucous epidermal nevus with etanercept.

Arch Dermatol. 2006 Mar;142(3):401-2. doi: 10.1001/archderm.142.3.401.

引用本文的文献

1

Bilateral Systematised Epidermolytic Epidermal Nevus: A case report.双侧系统性表皮松解性表皮痣：病例报告。

Sultan Qaboos Univ Med J. 2021 Feb;21(1):e124-e126. doi: 10.18295/squmj.2021.21.01.018. Epub 2021 Mar 15.

2

The retinoids. A review of their clinical pharmacology and therapeutic use.维甲酸类药物。其临床药理学与治疗应用综述。

Drugs. 1987 Oct;34(4):459-503. doi: 10.2165/00003495-198734040-00003.